Debtset – Bailiff-Sheriff Aust MEMBER Login
How to keep innovation in good health: Innovation Series Sydney
GATHER three experts in medical research, nuclear medicine and food/bio science together and there are bound to be innovative discussions.
That is precisely what is happening at the next Innovation Series luncheon event on August 21 at the Westin Sydney hotel, when three experts consider the topic Improving Lives through Innovation - delivering a healthy future for Australia.
This far-reaching forward-looking event will not completely escape the embrace of the imminent Federal Election, however, as the recurrent theme of the roll-out of the National Broadband Network (NBN) and its impact on delivering e-health solutions, especially to remote communities, is sure to feature in the discussions.
The view of Professor Warwick Anderson, CEO of the National Health and Medical Research Council (NHMRC) is that innovation and investment in research are vital elements as Australia addresses future health challenges.
Prof. Anderson has vast experience in the R&D field and will offer evidence that health and medical research may have already delivered health and wealth to Australia - but we are going to become even more reliant on new research and its rapid translation "to deliver better quality care, more cost-effective care and sunrise industries".
His topic, How innovation can help Australia develop a sustainable, high quality health care system, is of particular interest in the lead-up to the Federal Election, placing the approaches of all the major political parties in perspective.
A global perspective, spanning a century and a half, on the value of innovation in healthcare and related industries is proven by the story of Bayer - an organisation with innovation in its DNA. The organisation was founded by Friedrich Bayer in 1863, in the German village of Wuppertal Barmen.
Bayer Australia and New Zealand senior representative, Dr Jacqueline Applegate will outline Bayer's fascinating history and its ongoing tradition of innovation and scientific R&D in life sciences, including plant, animal and human health.
Dr Applegate, in her role as managing director for Bayer CropScience, will explain how Bayer continues to accelerate its role as an advocate for innovation in food and health sciences to assist communities globally.
The Australian Nuclear Science and Technology Organisation (ANSTO) is one of the world's most prolific and successful developers and providers of medical isotopes - an area at the cutting edge of today's medical diagnosis and treatment capabilities.
Doug Cubbin, ANSTO general manager for International Commercial Partnerships, will outline the latest developments in nuclear medicine and its use in the diagnosis, management, treatment and prevention of serious disease - a fascinating and little-acknowledged area in which ANSTO is a world leader.
The Innovation Series provides a unique forum convening researchers, industry and government to address and discuss leading developments in sustainability, while also encouraging the exchange of ideas and inviting new collaborations.
The Innovation Series, developed by Zernike Australia, is presented in Melbourne, Sydney and Brisbane three times a year. Partners in the Innovation Series Sydney include the Australian Institute for Commercialisation, Bayer, CSIRO, ANSTO and Shelston IP. Business Acumen has been the media partner of the Innovation Series since its inception in Queensland in 2004.
http://www.innovationseries.com.au/
